| Primary |
| Hypertension |
68.3% |
| Diabetes Mellitus |
3.3% |
| Arthralgia |
2.7% |
| Type 2 Diabetes Mellitus |
2.7% |
| Blood Pressure Increased |
2.4% |
| Coronary Artery Disease |
2.4% |
| Depression |
2.2% |
| Anxiety |
1.6% |
| Atrial Fibrillation |
1.6% |
| Blood Cholesterol Increased |
1.6% |
| Embolism |
1.6% |
| Insomnia |
1.6% |
| Dyslipidaemia |
1.4% |
| Hypothyroidism |
1.1% |
| Osteoarthritis |
1.1% |
| Vertigo |
1.1% |
| Anaemia |
0.8% |
| Dementia Alzheimer's Type |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Pain |
0.8% |
|
| Death |
14.0% |
| Vogt-koyanagi-harada Syndrome |
10.8% |
| Vomiting |
8.6% |
| Hypokalaemia |
6.5% |
| Renal Failure Acute |
6.5% |
| Bradycardia |
4.3% |
| Fall |
4.3% |
| Hyponatraemia |
4.3% |
| Myocardial Infarction |
4.3% |
| Syncope |
4.3% |
| Asthenia |
3.2% |
| Asthma |
3.2% |
| Blood Pressure Inadequately Controlled |
3.2% |
| Fatigue |
3.2% |
| Headache |
3.2% |
| Hypertension |
3.2% |
| Insomnia |
3.2% |
| Loss Of Consciousness |
3.2% |
| Pancreatitis |
3.2% |
| Pruritus |
3.2% |
|
| Secondary |
| Hypertension |
29.1% |
| Product Used For Unknown Indication |
25.6% |
| Drug Use For Unknown Indication |
7.2% |
| Diabetes Mellitus |
3.9% |
| Dyslipidaemia |
3.5% |
| Myocardial Ischaemia |
3.5% |
| Cardiac Failure Chronic |
3.3% |
| Blood Pressure Increased |
3.1% |
| Type 2 Diabetes Mellitus |
3.1% |
| Arthralgia |
2.6% |
| Overdose |
2.6% |
| Thrombosis Prophylaxis |
2.0% |
| Anxiety |
1.8% |
| Tendonitis |
1.8% |
| Hiv Infection |
1.3% |
| Prophylaxis |
1.3% |
| Atrial Fibrillation |
1.1% |
| Cardiac Failure |
1.1% |
| Colon Cancer |
1.1% |
| Ill-defined Disorder |
1.1% |
|
| Renal Failure Acute |
10.6% |
| Hyponatraemia |
7.4% |
| Pulmonary Embolism |
7.4% |
| Anaemia Haemolytic Autoimmune |
6.4% |
| Completed Suicide |
6.4% |
| Myocardial Infarction |
6.4% |
| Vomiting |
6.4% |
| Multi-organ Failure |
5.3% |
| Sudden Death |
5.3% |
| Weight Increased |
5.3% |
| Depressed Level Of Consciousness |
4.3% |
| Hypokalaemia |
4.3% |
| Shunt Occlusion |
4.3% |
| Syncope |
4.3% |
| Renal Failure |
3.2% |
| Transaminases Increased |
3.2% |
| Weight Decreased |
3.2% |
| Acute Generalised Exanthematous Pustulosis |
2.1% |
| Angina Pectoris |
2.1% |
| Atrial Fibrillation |
2.1% |
|
| Concomitant |
| Hypertension |
24.0% |
| Product Used For Unknown Indication |
15.8% |
| Drug Use For Unknown Indication |
9.9% |
| Hepatitis C |
7.2% |
| Type 2 Diabetes Mellitus |
7.0% |
| Diabetes Mellitus |
6.1% |
| Rheumatoid Arthritis |
4.1% |
| Atrial Fibrillation |
3.2% |
| Prophylaxis |
3.0% |
| Non-small Cell Lung Cancer |
2.8% |
| Hypercholesterolaemia |
2.6% |
| Multiple Myeloma |
2.3% |
| Colorectal Cancer Metastatic |
1.9% |
| Cardiac Failure |
1.8% |
| Arrhythmia |
1.6% |
| Hyperuricaemia |
1.5% |
| Essential Hypertension |
1.4% |
| Osteoporosis |
1.4% |
| Depression |
1.3% |
| Hypothyroidism |
1.2% |
|
| Vomiting |
15.2% |
| Renal Failure Acute |
8.9% |
| Myalgia |
8.0% |
| Malaise |
6.3% |
| Nausea |
5.4% |
| Renal Failure |
5.4% |
| Rib Fracture |
4.5% |
| Anaemia |
3.6% |
| Bradycardia |
3.6% |
| Death |
3.6% |
| Decreased Appetite |
3.6% |
| Drug Interaction |
3.6% |
| Oesophagitis |
3.6% |
| Pancreatitis Acute |
3.6% |
| Pericarditis |
3.6% |
| Photosensitivity Reaction |
3.6% |
| Pulmonary Tuberculosis |
3.6% |
| Renal Impairment |
3.6% |
| Tachycardia |
3.6% |
| Weight Decreased |
3.6% |
|
| Interacting |
| Back Pain |
50.0% |
| Drug Use For Unknown Indication |
50.0% |
|
| Renal Failure Acute |
100.0% |
|
